Cargando…

Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model

BACKGROUND AND OBJECTIVES: Little is known about the sarcopenia transition process across different stages among Chinese community-dwelling older adults. We aimed to explore dynamic transitions of sarcopenia and its influencing factors in Chinese older adults. RESEARCH DESIGN AND METHODS: Data were...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Boran, Li, Shatao, Wang, Yanbo, Xiao, Wenbo, Zhao, Han, Liu, Xuewei, Liu, Yang, Lu, Xinlin, Gao, Bei, Zhou, Jiangtao, Wang, Bingyi, Wang, Yuan, Chen, Yongjie, Lu, Wenli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637947/
https://www.ncbi.nlm.nih.gov/pubmed/37954524
http://dx.doi.org/10.1093/geroni/igad105
_version_ 1785133507972956160
author Sun, Boran
Li, Shatao
Wang, Yanbo
Xiao, Wenbo
Zhao, Han
Liu, Xuewei
Liu, Yang
Lu, Xinlin
Gao, Bei
Zhou, Jiangtao
Wang, Bingyi
Wang, Yuan
Chen, Yongjie
Lu, Wenli
author_facet Sun, Boran
Li, Shatao
Wang, Yanbo
Xiao, Wenbo
Zhao, Han
Liu, Xuewei
Liu, Yang
Lu, Xinlin
Gao, Bei
Zhou, Jiangtao
Wang, Bingyi
Wang, Yuan
Chen, Yongjie
Lu, Wenli
author_sort Sun, Boran
collection PubMed
description BACKGROUND AND OBJECTIVES: Little is known about the sarcopenia transition process across different stages among Chinese community-dwelling older adults. We aimed to explore dynamic transitions of sarcopenia and its influencing factors in Chinese older adults. RESEARCH DESIGN AND METHODS: Data were derived from the China Health and Retirement Longitudinal Study. A total of 2856 older adults with complete data in the 2011, 2013, and 2015 waves were included in our study. Participants were categorized into 3 states: no sarcopenia, possible sarcopenia, and sarcopenia according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Continuous-time multistate Markov model was performed to estimate the 1-year transition probabilities and the associated factors of sarcopenia transitions. The association strength was expressed as hazard ratio and 95% confidence interval. RESULTS: The progression and reversion rates between no sarcopenia and sarcopenia state were 6.01 and 9.20 per 100 person-years, respectively. The 1-year progression probability to possible sarcopenia was higher compared with the likelihood of moving to the sarcopenia state (0.127 vs 0.034). The reversion probability to no sarcopenia was also higher among those with possible sarcopenia (0.281 vs 0.157). Older age, rural living, worse cognition status, higher chronic disease numbers, and lower nutrition status measured by body mass index accelerated the sarcopenia progression. Cognition status and body mass index level were related to higher chances of reverting. DISCUSSION AND IMPLICATIONS: Possible sarcopenia might be a critical time window to promote sarcopenia reversion. Timely interventions aimed at delaying the progression and facilitating sarcopenia recovery should focus on improving cognitive function and nutrition levels.
format Online
Article
Text
id pubmed-10637947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106379472023-11-11 Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model Sun, Boran Li, Shatao Wang, Yanbo Xiao, Wenbo Zhao, Han Liu, Xuewei Liu, Yang Lu, Xinlin Gao, Bei Zhou, Jiangtao Wang, Bingyi Wang, Yuan Chen, Yongjie Lu, Wenli Innov Aging Original Research Article BACKGROUND AND OBJECTIVES: Little is known about the sarcopenia transition process across different stages among Chinese community-dwelling older adults. We aimed to explore dynamic transitions of sarcopenia and its influencing factors in Chinese older adults. RESEARCH DESIGN AND METHODS: Data were derived from the China Health and Retirement Longitudinal Study. A total of 2856 older adults with complete data in the 2011, 2013, and 2015 waves were included in our study. Participants were categorized into 3 states: no sarcopenia, possible sarcopenia, and sarcopenia according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Continuous-time multistate Markov model was performed to estimate the 1-year transition probabilities and the associated factors of sarcopenia transitions. The association strength was expressed as hazard ratio and 95% confidence interval. RESULTS: The progression and reversion rates between no sarcopenia and sarcopenia state were 6.01 and 9.20 per 100 person-years, respectively. The 1-year progression probability to possible sarcopenia was higher compared with the likelihood of moving to the sarcopenia state (0.127 vs 0.034). The reversion probability to no sarcopenia was also higher among those with possible sarcopenia (0.281 vs 0.157). Older age, rural living, worse cognition status, higher chronic disease numbers, and lower nutrition status measured by body mass index accelerated the sarcopenia progression. Cognition status and body mass index level were related to higher chances of reverting. DISCUSSION AND IMPLICATIONS: Possible sarcopenia might be a critical time window to promote sarcopenia reversion. Timely interventions aimed at delaying the progression and facilitating sarcopenia recovery should focus on improving cognitive function and nutrition levels. Oxford University Press 2023-09-20 /pmc/articles/PMC10637947/ /pubmed/37954524 http://dx.doi.org/10.1093/geroni/igad105 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Gerontological Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Sun, Boran
Li, Shatao
Wang, Yanbo
Xiao, Wenbo
Zhao, Han
Liu, Xuewei
Liu, Yang
Lu, Xinlin
Gao, Bei
Zhou, Jiangtao
Wang, Bingyi
Wang, Yuan
Chen, Yongjie
Lu, Wenli
Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title_full Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title_fullStr Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title_full_unstemmed Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title_short Sarcopenia Transitions and Influencing Factors Among Chinese Older Adults With Multistate Markov Model
title_sort sarcopenia transitions and influencing factors among chinese older adults with multistate markov model
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637947/
https://www.ncbi.nlm.nih.gov/pubmed/37954524
http://dx.doi.org/10.1093/geroni/igad105
work_keys_str_mv AT sunboran sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT lishatao sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT wangyanbo sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT xiaowenbo sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT zhaohan sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT liuxuewei sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT liuyang sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT luxinlin sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT gaobei sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT zhoujiangtao sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT wangbingyi sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT wangyuan sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT chenyongjie sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel
AT luwenli sarcopeniatransitionsandinfluencingfactorsamongchineseolderadultswithmultistatemarkovmodel